Preliminary Trial Results For Possible COVID-19 Treatments Expected In 3 Weeks, WHO Says, Notes Vaccine Research Being Fast-Tracked

CNBC: Early trial results for potential coronavirus treatments expected in 3 weeks, WHO says
“Preliminary results from two clinical trials testing potential treatments for the COVID-19 coronavirus are expected in three weeks, the World Health Organization said Thursday. … In the meantime, scientists are also working quickly to produce a vaccine candidate to be ready for human clinical trials. U.S. health officials are fast-tracking work on a coronavirus vaccine, hoping to start an early-stage trial within the next two and a half months, the Trump administration said earlier this month…” (Lovelace, 2/20).

Additional coverage of research into COVID-19 treatments and vaccines, as well as how the outbreak is impacting research scientists’ work in China, is available from Forbes, The Guardian, NPR, and Science.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.